Abstract

Until technologies reach people through public health or other sectoral agencies, they will not be addressing the basic needs of the people for whom they are meant. In developing technologies, the initial phases may not often address a priority, but they always address a need. In order for developing technologies to be effective, there should be a strong information base which provides applied research institutions, pharmaceutical manufacturers, vaccine agencies, and the government enough data to translate the technologies into policies and products that could ultimately be integrated into the healthcare delivery system. For such matrices to be successful, we need an integrated approach toward fulfilling stakeholders' needs based on disease burden, mortality figures, and economic impact. [To view this article, please download the PDF.]